SHORT-TERM NOTES RECEIVABLE (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
May 12, 2026 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Short-Term Debt [Line Items] | ||||||
| Principal amount | $ 4,166,900 | |||||
| Accrued interest | $ 4,898,060 | |||||
| Accrued interest on short-term note receivable | $ 277,550 | $ 251,304 | ||||
| Allowance for credit losses | 142,574 | 468,000 | ||||
| Carrying value | $ 475,844 | 475,844 | ||||
| Loss on settlement of short-term note receivable | $ 375,844 | 375,844 | ||||
| Location, Statement of Income, Balance [Axis]: us-gaap:OtherIncomeMember | ||||||
| Short-Term Debt [Line Items] | ||||||
| Accrued interest on short-term note receivable | 275,358 | |||||
| Marizyme Notes [Member] | ||||||
| Short-Term Debt [Line Items] | ||||||
| Interest rate | 18.00% | |||||
| Royalty Expense | $ 100,000 | |||||
| Proceeds from Legal Settlements | 100,000 | |||||
| Revenue | $ 20 | |||||
| X | ||||||||||
- Definition Accrued interest on short-term note receivable. No definition available.
|
| X | ||||||||||
- Definition Loss on settlement of short-term note receivable. No definition available.
|
| X | ||||||||||
- Definition Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average effective interest rate during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of interest payable on debt, including, but not limited to, trade payables. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Cash received for the settlement of litigation during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense related to credit loss from transactions other than loan and lease transactions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|